AbbVie Inc. (ABBV) Inks Licensing Agreement for Pain Medicines Development

AbbVie Inc. (NYSE:ABBV) is one of the top S&P 500 stocks by index weight. On April 13, AbbVie Inc. (NYSE:ABBV) entered into an exclusive licensing agreement with Haisco Pharmaceutical Group for the development of pain medicines. Under the terms of the agreement, AbbVie will own the rights to develop, manufacture, and commercialize novel pain treatment […]